We have identified C7orf11, which localizes to the nucleus and is expressed in fetal hair follicles, as the first disease gene for nonphotosensitive trichothiodystrophy (TTD). C7orf11 maps to chromosome 7p14, and the disease locus has been designated "TTDN1" (TTD nonphotosensitive 1). Mutations were found in patients with Amish brittlehair syndrome and in other nonphotosensititive TTD cases with mental retardation and decreased fertility but not in patients with Sabinas syndrome or Pollitt syndrome. Therefore, genetic heterogeneity in nonphotosensitive TTD is a feature similar to that observed in photosensitive TTD, which is caused by mutations in transcription factor II H (TFIIH) subunit genes. Comparative immunofluorescence analysis, however, suggests that C7orf11 does not influence TFIIH directly. Given the absence of cutaneous photosensitivity in the patients with C7orf11 mutations, together with the protein's nuclear localization, C7orf11 may be involved in transcription but not DNA repair.
We have identified C7orf11, which localizes to the nucleus and is expressed in fetal hair follicles, as the first disease gene for nonphotosensitive trichothiodystrophy (TTD). C7orf11 maps to chromosome 7p14, and the disease locus has been designated "TTDN1" (TTD nonphotosensitive 1). Mutations were found in patients with Amish brittlehair syndrome and in other nonphotosensititive TTD cases with mental retardation and decreased fertility but not in patients with Sabinas syndrome or Pollitt syndrome. Therefore, genetic heterogeneity in nonphotosensitive TTD is a feature similar to that observed in photosensitive TTD, which is caused by mutations in transcription factor II H (TFIIH) subunit genes. Comparative immunofluorescence analysis, however, suggests that C7orf11 does not influence TFIIH directly. Given the absence of cutaneous photosensitivity in the patients with C7orf11 mutations, together with the protein's nuclear localization, C7orf11 may be involved in transcription but not DNA repair.
Trichothiodystrophy (TTD), or sulfur-deficient brittle hair (Price et al. 1980) , can be associated with a spectrum of symptoms affecting organs of ectodermal and neuroectodermal origin (table 1) . These include nail dystrophy, mental and growth retardation, ichthyosis, decreased fertility, and cutaneous photosensitivity, but not cancer (Bergmann and Egly 2001) . Approximately half of patients with TDD display photosensitivity. These cases are associated with defects in nucleotide excision repair (NER) due to mutations in XPD (Botta et al. 1998) , XPB (Weeda et al. 1997 ), or TTD-A (Giglia-Mari et al. 2004 ) that cause a reduction of cellular concen-tration of transcription factor II H (TFIIH) (Botta et al. 2002) . However, the causal gene or genes for nonphotosensitive TTD are unknown.
Amish brittle-hair brain syndrome (ABHS [MIM 234050]) is an autosomal recessive disorder characterized by short stature, intellectual impairment, sulfurdeficient brittle hair, and decreased male fertility but not cutaneous photosensitivity (Jackson et al. 1974; Baden et al. 1976 ). Other forms of nonphotosensitive TTD, such as Sabinas brittle-hair syndrome (MIM 211390) (Howell et al. 1981 ) and Pollitt syndrome (MIM 275550) (Pollitt et al. 1968) , were hypothesized to be allelic with ABHS, because of similar clinical presentations. Initially, to search for the ABHS disease locus, we performed homozygosity mapping on a subset of affected members from a consanguineous Amish kindred (Jackson et al. 1974 ) and identified a 2-Mb candidate locus on 7p14 ( fig. 1A) (Seboun et al., in press ). We then analyzed seven genes ( fig. 1A) (Scherer et al. 2003 ; The
Figure 1
Identification of C7orf11 mutations. To screen the two exons and the 5 upstream region of the C7orf11 gene, we used three sets of primer pairs: C7orf11-5upF/ex1R1, C7orf11ex1-F2/R3, and C7orf11ex2-F/R2 (for primer sequences, see table A1 [online only]). The cycling conditions were initial denaturation at 94ЊC for 3 min followed by 35 cycles of denaturation at 94ЊC for 30 s, annealing at 58ЊC for 30 s, and extension at 72ЊC for 60 s. PCR products were purified using microCLEAN (Microsone) and were used as the sequencing template. Sequencing reactions were performed using the Big Dye Terminator kit (Applied Biosystems), and an ABI-3730 DNA Sequencer (Applied Biosystems) was used to obtain sequences. A, Physical map of the 2-Mb region on 7p14 showing homozygosity in a consanguineous Amish kindred. B, Diagram of C7orf11, consisting of two exons spanning 2 kb. The coding and untranslated regions are shown as blackened and unblackened boxes, respectively. The red and blue asterisks (*) indicate the position of the M144V mutation in the Amish kindred and the 2-bp deletion in the Moroccan siblings with TTD, respectively. Black and red bars (numbered from 1 to 11) represent the size and location of the PCR products in the deletion mapping for patient 6474. The fragments that were not amplified from patient 6474 (because of homozygous deletion) are indicated by red bars. C, Five affected families from the Amish kindred. Gray and blackened symbols indicated affected members, and unblackened symbols indicate unaffected members. The member of family B represented by the blackened symbol is the proband, who had a more severe phenotype, presumably due to a de novo chromosomal abnormality (46,XY,14q Ϫ ) (Jackson et al. 1974) . The genotype at the M144V mutation site (A, wild-type; G, mutated) is shown for each member. D, Electropherograms for the M144V site. E, Representative results (from test primers 3, 4, 6, and 10) of the PCR-based deletion mapping of the C7orf11 locus in patient 6474 (lane C, control; lane P, patient 6474). Unblackened triangles indicate the 704-bp fragment amplified by control primer DJg5/g6. The blackened triangles indicate the fragment amplified by a test primer pair. The cycling conditions were initial denaturation at 94ЊC for 3 min followed by 36 cycles of denaturation at 94ЊC for 30 s, annealing at 58ЊC for 30 s, and extension at 72ЊC for 75 s. Detailed information for the 11 test primers pairs and the control primer pair is available in table A1 (online only).
Figure 2
A, The human C7orf11 protein. The glycine/proline-rich region is shown in green (the low-complexity regions detected by the BLASTP program are in light green). There are two highly conserved C terminal regions (CR1 and CR2) among the candidate orthologues. The evolutionary tree (middle) was drawn by the ClustalX program (Thompson et al. 1997 ). The protein sequences used for phylogenetic analysis are human C7orf11 (NCBI accession number NP_619646) and orthologues from chimpanzee (Ensembl accession number ENSPTRP00000032652), mouse (NCBI accession number BAB27916), rat (Ensembl accession number ENSRNOP00000018746), chicken (Ensembl accession number ENSGALP00000020100), frog (Xenopus tropicalis [NCBI accession number NP_989025]), pufferfish (Tetraodon nigroviridis [NCBI accession number CAF91712]), fruit fly (Drosophila melanogaster [NCBI accession number NP_648690]), and mosquito (Anopheles gambiae [NCBI accession number XP_318005]). Deduced protein sequences were derived from cDNA sequences from zebrafish (Danio rerio [GenBank accession number BC062385]) and pig (GenBank accession number BP456435). The dog protein sequence was predicted from the genomic DNA sequence (see UCSC Genome Browser Web site). For each species, the overall amino acid similarity with the human protein sequence, the percentage ratio of glycine/proline content in the region from the N terminus to CR1, and the presence (ϩ) or absence (Ϫ) of CR1 and CR2 are shown. Multiple sequence alignments for CR1 and CR2 are at bottom. The position of M144V in CR2 is indicated by a red asterisk (*). Identical and similar amino acids are highlighted in dark and light blue, respectively. B, Subcellular localization assay. Transiently expressed Myc-tagged C7orf11 in human cultured cells (transformed human embryonic kidney cells [HEK293] and SV40-transformed WI38 human embryonic fibroblasts [VA13]) was examined by immunostaining, by use of anti-Myc antibody and a secondary antibody conjugated with fluorescein isothiocyanate (FITC). Bright-field (BF), 4'-6-diamidino-2-phenylindole (DAPI), FITC, and the merged image of DAPI and FITC signals are shown for each cell line. The Myc-tagged cDNA construct for C7orf11 was generated by inserting the coding region of C7orf11 (nucleotides 51-590 of mRNA) in pcDNA3.1ϩ Myc-His A (Invitrogen). DNA transfection was performed using Lipofectamine Plus (Invitrogen). Two days after transfection, cells were washed in PBS and were fixed in 50% acetone plus 50% methanol at Ϫ20ЊC for 15 min. The samples were blocked with 10% BSA in PBS (blocking buffer) for 1 h and were incubated in blocking buffer containing anti-Myc antibody (Santa Cruz Biotechnology) for 45 min. Cells were washed three times with PBS, were incubated with FITC-conjugated anti-mouse IgG antibody for 30 min, and were washed three times with PBS. After DAPI staining, the samples were analyzed by deconvolution microscopy (Zeiss). C, In situ RNA hybridization for C7orf11 on human fetal skin tissue. A 556-bp cDNA fragment (corresponding to nucleotides 303-858 of mRNA) was subcloned in pCR-Script (Stratagene) and was used as template DNA to synthesize [
35 S]UTP-labeled riboprobes. [
35 S]UTP-labeled riboprobes (sense and antisense) were hybridized to the sections. Radioactive signals were detected by autoradiography with 38 d of exposure. Slides were counterstained with hematoxylin-eosin and were photographed under dark-field (DF) and bright-field (BF) illumination. The signal detected in epidermis and hair follicles is specific to the antisense probe. The detail conditions used for hybridization, washing, and signal detection were described elsewhere (Saarialho-Kere et al. 1992) . D, Normal level of TFIIH in fibroblast cells from one of the Moroccan siblings with the 2-bp deletion. Mixed DAPI/phase contrast image (top) showing a normal (with large beads) and TTD (with small beads) cells. Immunofluorescence with anti-XPB antibody (bottom). For exact quantitative comparison of fluorescence signals between normal and TTD fibroblasts without slideto-slide variability, two types of fibroblasts were preloaded with cytoplasmic plastic beads of different sizes (large beads for normal and small beads for TTD) and then were mixed, cultured overnight, and processed for immunofluorescence.
Chromosome 7 Annotation Project [see Web site]) by DNA sequencing and identified three homozygous sequence variations in the affected members of family E ( fig. 1C ): a TrC variant in intron 7 of C7orf10, a GrA variant in exon 1 of CDC2L5 causing an arginine-tolysine substitution (R21K), and an ArG variant in exon 2 of C7orf11 causing a methionine-to-valine substitution (M144V). The first two sequence variations were excluded from further analysis, because the same genotype was found in either normal controls or the unaffected parents in family E. We have shown elsewhere that C7orf11 encodes a 179-aa protein of unknown function (Nakabayashi et al. 2002) and that it is variably expressed in many tissues, including fibroblasts and brain. By sequencing all available members of the Amish kindred, we confirmed that all 13 affected cases were homozygous for the ArG variant and that 26 unaffected members were either heterozygous carriers (18/26) or homozygous for the normal allele (8/26) ( fig. 1C and  1D ). We genotyped 148 controls (296 chromosomes), including 48 unrelated Amish individuals, and confirmed cosegregation of the M144V variant in only carrier or disease chromosomes.
We then examined C7orf11 in 12 additional cases of nonphotosensitive TTD and found two deleterious homozygous deletions. In siblings of Moroccan origin with TTD (Przedborsk et al. 1990 ), we found a 2-bp homozygous deletion in exon 1 (nucleotides 187 and 188 of C7orf11 mRNA [GenBank accession number NM_138701]) (data not shown), which predicts a 57-aa truncated protein. In another case-an Italian patient with TTD and severe nervous-system impairment (patient 6474) )-our attempts to amplify the coding regions of C7orf11 failed. By multiplex PCR using a primer pair that amplifies a 704-bp control fragment, we determined that part of exon 1 and the entire exon 2 of C7orf11 were homozygously deleted, whereas the flanking genes (CDC2L5 and C7orf10) were not ( fig.  1B and 1E ). These patients with homozygous deletions are likely to be genetically null for C7orf11, which might explain their more-severe neurological phenotype in comparison with that of the patients with ABHS. We did not find any mutations in the two exons and 5 upstream region of C7orf11 in the other 10 cases of nonphotosensitive TTD, including two cases of Sabinas syndrome and one case of Pollitt syndrome, which suggests that genetic heterogeneity exists in nonphotosensitive TTD. The fibroblasts derived from all but two patients with Sabinas syndrome were tested for UV sensitivity by use of various NER parameters, including unscheduled Alfandari et al. 1993 Howell et al. 1981 Baden et al. 1976 Jackson et al. 1974 Przedborski et al. 1990 Pollitt et al. 1968 Rizzo et al. 1992 Stefanini et al. 1992 Jorizzo et al. 1982 a ND p not determined; ϩ p presence; Ϫ p absence. b The isolated TTD cases and the ichthyosis, brittle hair, impaired intelligence, decreased fertility, and short stature (IBIDS) cases were not analyzed in this study but are included in the table to show the extent of the spectrum of TTD symptoms.
c Mild.
d Ichthyosiform areas present only on the lower limbs. e Male only. f Gonadal dysfunction tested. g UV sensitivity tests were performed using various NER parameters, including unscheduled DNA synthesis (global NER), recovery from transcription inhibition (transcription-coupled NER), and overall clonogenic cell survival after UV exposure.
h GenBank accession number NM_138701.
DNA synthesis, recovery from transcription inhibition, and overall clonogenic cell survival after UV exposure. Microsatellite analysis also excluded the 2-Mb C7orf11 locus from involvement in Sabinas syndrome. Therefore, we have designated C7orf11 with the symbol TTDN1 (TTD nonphotosensitive 1). We identified predicted proteins with sequence similarity to human C7orf11 in six mammalian species as well as chicken, frog, fish, and insects, but not in lower eukaryotic species (C. elegans and yeast). The first twothirds of the human C7orf11 protein is remarkably glycine/proline-rich (45% in 125 aa), and this feature is more evident in higher eukaryotic species ( fig. 2A ). There are two highly conserved regions: CR1, conserved from zebrafish to human, and CR2, conserved from mosquito to human ( fig. 2A) . The mutant M144V found in patients with ABHS is located in the three amino acid residues (SML) in CR2 that are conserved in all species. To examine the subcellular localization of C7orf11, we transfected Myc-epitope-tagged protein into cultured mammalian cells and found that it was predominantly expressed in the nucleus (fig. 2B) ; the pattern of the Mycepitope-mutated protein was indistinguishable from the wild type (data not shown). We performed in situ RNA hybridization analysis for C7orf11 in human fetal skin tissue and found that it was expressed in epidermis and hair follicles, consistent with presentation of the phenotype ( fig. 2C ). C7orf11 expression was not clearly detected in dermis by in situ hybridization, but it was found by RT-PCR in fibroblast cells.
To examine whether C7orf11 mutations affect TFIIH cellular concentration, we performed comparative immunofluorescence analysis, using antibody against the xeroderma pigmentosum group B protein (XPB) (a core component of TFIIH), and found that the TFIIH levels in normal controls and in fibroblasts from a patient with TTD (one of the Moroccan siblings with the 2-bp deletion) are the same ( fig. 2D ). This result, combined with the observation that mutations could not be detected in any of TFIIH subunits and with the genetic mapping data (not shown), suggests that the defect in nonphotosensitive TTD is independent of TFIIH action.
To our knowledge, C7orf11 is the first gene identified as mutated in patients with nonphotosensitive TTD. Since these mutations were found in only a subset of nonphotosensitive TTD cases, it is likely that there is more than one disease-causing gene, as was found for photosensitive TTD. Photosensitive TTD is caused by mutations in genes encoding subunits (XPD, XPB, and TTD-A) of the TFIIH complex that functions in transcription and DNA repair. Since there is an absence of cutaneous photosensitivity in the patients with C7orf11 mutations and since the protein demonstrates a nuclear localization, it is possible that C7orf11 may have a role in transcriptional processes but have no role in DNA repair. Moreover, the brittle hair observed in patients with TTD is thought to result from the reduced expression of high-sulfur proteins (intermediate keratin filaments and matrix proteins) in the late stage of keratinocyte differentiation (Bergmann and Egly 2001) . Genes in these pathways and/or proteins associated with C7orf11 would be the primary candidates for involvement in other nonphotosensitive TTD cases.
